Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Abdulraheem Yacoub(The University of Kansas Cancer Center), Ronald Hoffman(Icahn School of Medicine at Mount Sinai), Noushin Farnoud(Memorial Sloan Kettering Cancer Center), Vittorio Rosti(Istituti di Ricovero e Cura a Carattere Scientifico), Murat O. Arcasoy(Duke University), Maria Chiara Finazzi(Ospedale Papa Giovanni XXIII), Lonette Sandy(Icahn School of Medicine at Mount Sinai), Damiano Rondelli(University of Illinois Chicago), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Craig M. Kessler(Georgetown University), Heidi Kosiorek(Mayo Clinic in Florida), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Richard T. Silver(Cornell University), Josef T. Prchal(Huntsman Cancer Institute), Vesna Najfeld, Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Maria R. Baer(University of Maryland, Baltimore), Joseph Tripodi(Icahn School of Medicine at Mount Sinai), Rona Singer-Weinberg(New York Blood Center), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Marina Kremyanskaya(Tisch Cancer Institute), D Leibowitz(Sutter Health), Tiziano Barbui(University of Bergamo), John Mascarenhas(Tisch Hospital), Raajit K. Rampal(Memorial Sloan Kettering Cancer Center), Elli Papaemmanuil(Memorial Sloan Kettering Cancer Center), Rosalind Catchatourian(John H. Stroger, Jr. Hospital of Cook County), Ellen K. Ritchie(Cornell University), Amylou C. Dueck(Mayo Clinic in Arizona), Elizabeth O. Hexner(University of Pennsylvania), Elliott F. Winton(Emory University), Judith D. Goldberg(New York University), Dmitry Berenzon(University Medical Center), Joseph Vadakara(Geisinger Medical Center)
Cited by 175
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k